β-radiation exposure with 188Re-labelled pharmaceuticals

NuklearMedizin

Volumn 44, Issue 3, 2005, Pages 94-98

  Andreeff, M ^a,c   Wunderlich, G ^a   Behge, K ^b   Schonmuth Th ^b   Kotzerke, J ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Fachbereich Strahlenschutz   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Radiation protection; Skin dose exposure; particle dosimetry

Indexed keywords

RHENIUM 188; RADIOPHARMACEUTICAL AGENT; RHENIUM;

ARTICLE; BETA RADIATION; COMPARATIVE STUDY; CONTROLLED STUDY; DOSIMETER; HUMAN; PERSONNEL RADIATION MONITORING; PHARMACIST; PHYSICIAN; RADIATION ABSORPTION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION MEASUREMENT; RADIOTHERAPY; THERMOLUMINESCENCE DOSIMETER; FINGER; NEOPLASM; THERMOLUMINESCENCE DOSIMETRY;

BETA RAYS; FINGERS; HUMANS; NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RHENIUM; THERMOLUMINESCENT DOSIMETRY;

EID: 20444459152     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625712     Document Type: Article

References (14)

1. Andreeff M, Wunderlich G, Runge R et al. Strahlenschutzverbesserung durch Einsatz einer Vorrichtung zur teilautomatischen Elution und Konzentrierung von W-188/Re-188-Generator-Eluaten. Nuklearmedizin 2004; 43: A117.
2. 188Re-labeled anti-CD66(a,b,c,e) monoclonal antibody to intensify the conidtioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study. Blood 2001; 98: 565-72.
3. 188Re-filled balloon: six-month results from a clinical safety and feasibility study. Circulation 2000; 101: 2355-60.
4. Höher M, Wöhrle J, Wohlfrom M et al. Intracoronary beta-irradiation with a rhenium-188-filled balloon catheter: a randomized trial in patients with de novo and restenotic lesions. Circulation 2003; 107: 3022-7.
5. Liepe K, Andreeff M, Mielcarek J et al. Beta-radiation exposure at the finger tips during the radionuclide synovectomy. Nuklearmedizin 2003; 42:104-8.
6. Mobit PN, Nahum AE, Mayles P. The energy correction factor of LiF thermoluminescent dosemeters in megavoltage electron beams: Monte Carlo simulations and experiments. Phys Med Biol 1996; 41: 979-93.
7. Palmedo H, Bender H, Schomburg A et al. Pain therapy with rhenium-186 HEDP in multiple bone metastases. Nuklearmedizin 1996; 35: 63-7.
8. Palmedo H, Guhlke S, Bender H et al. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. Eur J Nucl Med 2000; 27: 123-30.
9. Reske SN, Bunjes D, Buchmann I et al. Targeted bone marrow irradiation in the conditioning of high risk leukemia prior to stem cell transplantation. Eur J Nucl Med 2001; 28: 807-15.
10. Runge R, Andreeff M, Mielcarek J et al. Strahlenschutzmaßnahmen beim Umgang mit Eluaten aus hochbeladenen W-188/Re-188-Generatoren. Nuklearmedizin 2001; 40: A72.
11. Sarfaraz M, Kennedy AS, Cao ZJ et al. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 2003; 30: 199-203.
12. Strahlenschutzkommission. Berechnungsgrundlage für die Ermittlung von Körperdosen bei äußerer Strahlenexposition durch Elektronen, inbesondere durch Beta-Strahlung. Stuttgart: Gustav Fischer 1991; Band 3.
13. Strahlenschutzkommission. Strahlenschutz bei der Therapie mit Beta-Strahlern in flüssiger Form im Rahmen einer Brachytherapie, Radiosynovior-these und einer Radioimmuntherapie. Nuklearmedizin 2003; 42: N63-4.
14. Wunderlich G, Pinkert J, Andreeff M et al. Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy. Appl Radiat Isot 2000; 52: 63-8.